Sapropterin Dihydrochloride Powder, For Solution
Product Images NDC 31722-047

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sapropterin Dihydrochloride (NDC 31722-047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sapropterindihydrochloridefigure1 (Sapropterindihydrochloridefigure1)

A line graph depicting blood phenylalanine (Phe) levels over time during study visits for two age groups receiving Sapropterin dihydrochloride: 1 month to less than 2 years (solid line) and 2 to less than 7 years (dashed line). The y-axis shows blood Phe levels (µmol/L), and the x-axis shows study visits including baseline, weeks, and months. A dotted line indicates target blood Phe control range.*

FDA Label Image

Sapropterindihydrochloridestructure (Sapropterindihydrochloridestructure)

Chemical structure of sapropterin dihydrochloride showing its molecular arrangement with labeled carbon positions and hydrochloride notation indicating the salt form.*

FDA Label Image

Sapropterindihydrochloridefigure2 (Sapropterindihydrochloridefigure2)

This line graph compares blood phenylalanine (Phe) levels over time between Sapropterin dihydrochloride and placebo groups across several study visits from weeks -2 to 6. Sapropterin dihydrochloride shows a significant decrease in blood Phe levels starting at week 0, while placebo levels remain consistently higher. Error bars indicate variability and a p-value less than 0.001 is noted.*

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Sapropterindihydrochloridefigurea (Sapropterindihydrochloridefigurea)

An instructional diagram illustrating the use of an oral dosing syringe. It shows labeled parts of the syringe including the barrel, tip, and plunger. Below are two cups labeled 'medicine cup' and 'water or apple juice cup,' indicating options for liquid administration.*

FDA Label Image

Sapropterindihydrochloridefigureb (Sapropterindihydrochloridefigureb)

An instructional illustration showing oral powder for solution being poured into a medicine cup. The image highlights a liquid measurement line on the cup to guide proper dosing.*

FDA Label Image

Sapropterindihydrochloridefigurec (Sapropterindihydrochloridefigurec)

An instructional illustration showing the pouring of powder from a packet into a medicine cup, labeled "medicine cup." This image likely demonstrates the preparation step for a powder medication for oral solution.*

FDA Label Image

Sapropterindihydrochloridefigured (Sapropterindihydrochloridefigured)

An instructional illustration showing a hand stirring liquid in a medicine cup with a stirring tool or utensil. The image is labeled 'medicine cup' to indicate the container used for oral medication preparation or administration.*

FDA Label Image

Sapropterindihydrochloridefiguree (Sapropterindihydrochloridefiguree)

An instructional illustration showing a hand holding a syringe above a medicine cup, with liquid being drawn or measured. The medicine cup is labeled as such. This likely demonstrates how to prepare or measure oral liquid medication for administration.*

FDA Label Image

Sapropterindihydrochloridefiguref (Sapropterindihydrochloridefiguref)

An instructional illustration showing a hand holding a syringe with labels indicating the "tip" and the "liquid line" within the syringe barrel. This type of diagram is typically used to demonstrate correct measurement or usage technique.*

FDA Label Image

Sapropterindihydrochloridefigureg (Sapropterindihydrochloridefigureg)

An instructional illustration showing a person receiving an oral dose of medication via a syringe without a needle. The syringe is being placed into the person's mouth by a caregiver's hand, demonstrating the oral administration of a liquid or solution drug.*

FDA Label Image

Sapropterindihydrochloridecarton100mg30s (Sapropterindihydrochloridecarton100mg30s)

Packaging label for Sapropterin Dihydrochloride Powder for Oral Solution 100 mg by Camber Pharmaceuticals, Inc. The carton contains 30 individual packets. Directions, storage instructions, and manufacturer details are provided on the label, emphasizing single-use packets and moisture protection.*

FDA Label Image

Sapropterindihydrochloridefoil100mg (Sapropterindihydrochloridefoil100mg)

Packaging label for Sapropterin dihydrochloride 100 mg powder for oral solution by Camber Pharmaceuticals, Inc. The label includes the product name, strength, dosage form, NDC 31722-047-01, and storage instructions. Directions for use and manufacturer information are also visible. The label is designed for a small powder packet with dimensions marked for printing.*

FDA Label Image

Sapropterindihydrochloridecarton500mg30s (Sapropterindihydrochloridecarton500mg30s)

Carton label for Sapropterin Dihydrochloride Powder for Oral Solution 500 mg single use packets by Camber Pharmaceuticals, Inc. The label indicates 30 single use packets per carton, each equivalent to 384 mg of sapropterin. Storage instructions and contact information are included along with NDC 31722-048-30.*

FDA Label Image

Sapropterindihydrochloridefoil500mg (Sapropterindihydrochloridefoil500mg)

Label for Sapropterin Dihydrochloride Powder for Oral Solution, 500 mg strength, by Camber Pharmaceuticals, Inc. The label indicates individual single-use packets each containing 500 mg of sapropterin dihydrochloride, equivalent to 384 mg of sapropterin base. Directions for use and storage instructions are also included, with the label showing two identical panels side by side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.